Journal
TRENDS IN BIOCHEMICAL SCIENCES
Volume 47, Issue 8, Pages 673-688Publisher
CELL PRESS
DOI: 10.1016/j.tibs.2022.03.018
Keywords
-
Categories
Funding
- Swiss National Science Foundation (SNSF) [407240_177368]
- Swiss National Science Foundation [310030_188817]
- SNSF Bridge grant [40B2-0_187170]
- European research Council (ERC) [772190]
- European Research Council (ERC) [772190] Funding Source: European Research Council (ERC)
- Swiss National Science Foundation (SNF) [407240_177368, 40B2-0_187170, 310030_188817] Funding Source: Swiss National Science Foundation (SNF)
Ask authors/readers for more resources
This article summarizes various biomolecules used for capturing live bacteria, including immune proteins, antibodies, aptamers, phage proteins, and antimicrobial peptides. The article also discusses the potential use of nanobodies targeting conserved surface-accessible proteins as promising biomolecules for pathogen capture.
Rapid phenotypic antimicrobial susceptibility testing (AST) requires the enrichment of live bacteria from patient samples, which is particularly challenging in the context of life-threatening bloodstream infections (BSIs) due to low bacterial titers. Over two decades, an extensive array of pathogen-specific biomolecules has been identified to capture live bacteria. The prevailing biomolecules are immune proteins of the complement system, antibodies, aptamers, phage proteins, and antimicrobial peptides. These biomolecules differ by their binder generation technologies and exhibit highly variable specificities, ranging from bacterial strains to most pathogenic bacteria. Here, we summarize how these diverse biomolecules were identified, list examples of successfully reported capture assays, and provide an outlook on the use of nanobodies raised against conserved surface-accessible proteins as promising biomolecules for pathogen capture.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available